Core Insights - Zhongkang Holdings (02361.HK) has made significant progress in the commercialization of AI large models and intelligent agents, covering various sectors including marketing, healthcare, pharmacies, and consumer management [1] Marketing - The company has launched the "AI Marketing Laboratory" and introduced the "Tiangong No. 1 · Commercial Intelligent Agent," providing "+AI" digital solutions to 182 pharmaceutical companies, enabling rapid response and efficient decision-making in a changing environment [1] Healthcare - In the healthcare sector, the company has developed the "Zhuomuniao Medical Large Model" and launched the intelligent agent "iMDT" for multidisciplinary joint consultations, serving 512 hospitals and empowering over 1,520 clinical doctors to enhance the quality of decision-making in complex medical diagnoses [2] Pharmacies - In the pharmacy sector, the company has introduced an intelligent agent that has served over 10,993 pharmacies, utilizing comprehensive industry data to establish a matrix of five AI intelligent agents covering operational insights, products, diseases, members, and employees, as well as specialized AI for "individuals, families, diseases, and medications" to empower store operations [3] Consumer Management - In health management, the company has created a matrix of AI intelligent agents covering "individuals, families, diseases, and medications," accurately reaching over 3 million users, providing personalized health interventions and risk warnings, and constructing a comprehensive management system that includes prevention, screening, and intervention [4]
中康控股(02361.HK)：在AI大模型及AI智能体的商业化应用方面取得显着进展